April 4 (Reuters) - Genfit Sa GNFT.PA :
* GENFIT REPORTS FULL-YEAR 2023 FINANCIAL RESULTS AND
PROVIDES
CORPORATE UPDATE
* : REVENUES AMOUNTED TO EUR 28.6 MILLION AS OF DECEMBER 31,
2023
INCLUDING A MILESTONE PAYMENT OF EUR 13.3 MILLION
* TOPLINE INTERIM DATA FOR PHASE 2 UNVEIL-IT(®) TRIAL IN
ACLF
EXPECTED IN 2H24
* : FDA PDUFA ACTION DATE FOR ELAFIBRANOR IN PBC: JUNE 10,
2024
* CASH AND CASH EQUIVALENTS TOTALED EUR 77.8 MILLION AS OF
DECEMBER 31, 2023
Source text for Eikon: ID:nGNE50MYnl
Further company coverage: GNFT.PA
((reuters.briefs@thomsonreuters.com;))